This Project extends the clinical investigative studies to animal models, with the overall goal of probing deeper into the mechanisms of estrogen (E) action on bone. Recently, a host of coregulators for E receptor (ER) action and of compounds with the ability to activate E signaling in a tissue specific manner (selective ER modulators, SERMs) have been identified. In the proposed studies, we will focus on two of the most important coactivators for ER action, steroid receptor coactivator (SRC)-I and the closely related SRC-2. Following activation of the ER by ligand, these coactivators bind to the ER and are critical in mediating E effects on target tissues. However, little is known about the role of these coactivators in mediating E action in bone, whether either can, at least partially, compensate for loss of the other, or how these coactivators may modulate the tissue specific actions of SERMs such as tamoxifen or raloxifene. In preliminary studies, we have shown that SRC-1 knock out (KO) mice have an impaired skeletal response to E, particularly in cancellous bone. We will use these and the SRC-2 KO mice to test the hypotheses that: (1) Both SRC-1 and -2 are important in mediating E effects on bone; (2) In the setting of loss of SRC-1 or -2, each coactivator can, at least partially, compensate for the absence of the other; (3) While E can have at least partial effects on bone in the setting of SRC-1 or -2 deficiency, SERMs will be completely ineffective; and (4) E action on bone (or least that component that requires SRC-1) is mediated via effects on cells in both the osteoblastic and osteoclastic lineages.
Our Specific Aims, therefore, are: (1) To better define the role of SRC-1 and -2, and their interactions, in mediating E action on the female mouse skeleton in vivo; (2) Using the SRC-1 and -2 KO mice, characterizing the role of these coactivators in SERM action in bone; and (3) Defining the extent to which selective replacement of SRC-1 in cells of either the osteoblastic or the osteoclastic lineages can correct the deficit in the skeletal effects of E that are present in the SRC-1 KO mice. When combined with the molecular studies on these same coactivators in Project 5, the proposed in vivo studies will help to provide a comprehensive picture of the role of these important coactivators in E and SERM action on bone, which is also likely to have significant clinical implications.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG004875-21
Application #
6758322
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5 (O2))
Project Start
2004-07-01
Project End
2009-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
21
Fiscal Year
2004
Total Cost
$194,480
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Xu, Ming; Pirtskhalava, Tamar; Farr, Joshua N et al. (2018) Senolytics improve physical function and increase lifespan in old age. Nat Med 24:1246-1256
Khosla, Sundeep; Farr, Joshua N; Kirkland, James L (2018) Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis. J Clin Endocrinol Metab 103:1282-1290
Rocca, Walter A (2018) The future burden of Parkinson's disease. Mov Disord 33:8-9
Rocca, Walter A; Gazzuola Rocca, Liliana; Smith, Carin Y et al. (2018) Personal, reproductive, and familial characteristics associated with bilateral oophorectomy in premenopausal women: A population-based case-control study. Maturitas 117:64-77
Drake, Matthew T; Fenske, Jennifer S; Blocki, Frank A et al. (2018) Validation of a novel, rapid, high precision sclerostin assay not confounded by sclerostin fragments. Bone 111:36-43
Laughlin-Tommaso, Shannon K; Khan, Zaraq; Weaver, Amy L et al. (2018) Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause 25:483-492
Farr, Joshua N; Weivoda, Megan M; Nicks, Kristy M et al. (2018) Osteoprotection Through the Deletion of the Transcription Factor Ror? in Mice. J Bone Miner Res 33:720-731
Wenning, Gregor; Trojanowski, John Q; Kaufmann, Horacio et al. (2018) Is multiple system atrophy an infectious disease? Ann Neurol 83:10-12
Kattah, Andrea G; Smith, Carin Y; Gazzuola Rocca, Liliana et al. (2018) CKD in Patients with Bilateral Oophorectomy. Clin J Am Soc Nephrol 13:1649-1658
Khosla, Sundeep; Monroe, David G (2018) Regulation of Bone Metabolism by Sex Steroids. Cold Spring Harb Perspect Med 8:

Showing the most recent 10 out of 401 publications